Saltar al contenido
Merck

Central neurocytoma responsive to topotecan, ifosfamide, carboplatin.

Pediatric blood & cancer (2008-03-14)
Elham Amini, Tina Roffidal, Alice Lee, Gregory N Fuller, Anita Mahajan, Leena Ketonen, Nathan Kobrinsky, Mitchell S Cairo, Robert J Wells, Johannes E A Wolff
RESUMEN

A 5-year-old male presented with spinal cord drop metastasis from a recurrent neurocytoma. Topotecan (0.5 mg/m(2)) and carboplatin (250 mg/m(2)) were administered on days 1-3 and ifosfamide (1,800 mg/m(2)) on days 1-5, every 21 days, for three cycles and resulted in complete response without severe complications. A literature review yielded 20 patients with central neurocytoma but no complete responses. The complete response of central neurocytoma to chemotherapy only reported here should be helpful to those caring for patients with this rare tumor.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ifosfamide, ≥98%
Ifosfamide, European Pharmacopoeia (EP) Reference Standard